SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,952.25 25.20
(0.05%)

Dow Jones

7,687.74 15.20
(0.20%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

95.92 -0.05
(-0.05%)

EUR-INR

108.79 -0.10
(-0.09%)

GBP-INR

127.19 0.21
(0.17%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Panacea Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531349

INE922B01023

43.0287126

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PANACEABIO

2192.16

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	413.49	309.86	359.60	257.07	235.50	343.56
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	413.49	309.86	359.60	257.07	235.50	343.56
Other Income	18.00	16.62	24.91	34.44	12.57	20.75
Stock Adjustments	12.42	23.06	-17.79	-31.15	60.95	-14.24
Total Income	443.91	349.54	366.72	260.36	309.02	350.07
EXPENDITURE :
Raw Materials	223.51	125.76	123.90	131.91	173.04	162.02
Power & Fuel Cost	26.43	28.46	25.33	22.43	26.51	20.78
Employee Cost	100.33	97.02	86.53	71.03	72.50	59.47
Other Manufacturing Expenses	37.90	41.12	48.20	36.31	40.76	45.75
Selling & Administrative Expenses	39.67	36.34	29.99	23.41	45.82	30.87
Miscellaneous Expenses	15.91	11.14	13.71	3.45	10.51	9.97
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	443.75	339.84	327.65	288.54	369.13	328.85
Operating Profit	0.18	9.69	39.07	-28.20	-60.11	21.21
Interest	25.31	15.46	13.78	10.06	7.04	7.52
Gross Profit	-25.13	-5.77	25.29	-38.26	-67.15	13.69
Depreciation	18.75	20.29	21.09	24.50	26.43	26.57
Profit Before Tax	-43.88	-26.06	4.20	-62.76	-93.58	-12.88
Tax	-1.59	0.00	0.64	0.00	0.00	2.27
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-12.38	-10.83	0.02	24.79	0.00	-0.71
Reported Net Profit	-29.91	-15.23	3.55	-87.54	-93.58	-14.44
Extraordinary Items	0.00	0.06	0.05	5.30	0.01	3.26
Adjusted Net Profit	-29.91	-15.29	3.50	-92.84	-93.59	-17.70
Adjustment below Net Profit	1.15	0.05	-0.06	-1.90	0.50	1.38
P & L Balance brought forward	-189.08	-173.91	-177.40	-87.96	5.12	18.18
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-217.84	-189.08	-173.91	-177.40	-87.96	5.12
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-4.88	-2.49	0.58	-14.29	-15.28	-2.36
Earnings Per Share(Adj)-Unit Curr	-4.88	-2.49	0.58	-14.29	-15.28	-2.36
Book Value-Unit Curr	43.03	47.72	50.20	49.63	64.24	79.43
Book Value(Adj)-Unit Curr	43.03	47.72	50.20	49.63	64.24	79.43

71,909.70 -570.59 ( -0.79%)

50,952.25 25.20 (0.05%)

7,687.74 15.20 (0.20%)

68,256.51 -700.21 (-1.02%)

10,455.36 27.09 (0.26%)

95.92 -0.05 (-0.05%)

108.79 -0.10 (-0.09%)

127.19 0.21 (0.17%)

0.61 0.00 (0.14%)